← Evidence map

ArticleDrug design, development and therapy

Does celecoxib inhibit agomelatine metabolism via CYP2C9 or CYP1A2?

Umit YasarPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 30034221